Literature DB >> 34725769

Long-term comparison of the outcomes of Ahmed Glaucoma Valve surgery between glaucoma surgeons and cornea trained surgeons.

Ramin Daneshvar1,2, Farshid Karimi3, Fatemeh Golami1, Seyed Aliasghar Mosavi4, Masoud Khorrami-Nejad5.   

Abstract

PURPOSE: To compare the long-term outcomes obtained by glaucoma surgeons versus cornea trained surgeons performing Ahmed glaucoma valve (AGV) surgery.
METHODS: Of the total 376 patients (3 month to 83 year) conducted in this retrospective study, 130 patients with refractory glaucoma were evaluated who had been followed up for at least six months during ten years period. The primary outcome measure was the surgical success of AGV surgery that was categorized in two groups: (A5 ≤ IOP ≤ 21 mmHg and at least 20% reduction in IOP without any glaucoma medications (complete success) and reduction by using one or more glaucoma medications (qualified success) (B) similar to previous criteria but the cutoff for higher IOP at 16 mmHg without vision loss and the need for medication or re-surgery.
RESULTS: Mean age of the patients was 32.99 ± 24.20 years in the glaucoma surgeon group and 25.18 ± 24.33 years in the cornea trained surgeons group (P = 0.07). The overall success of both methods at the end of four years were 66.7% and 41.7% for the group of glaucoma surgeons and cornea trained surgeons, respectively (p = 0.661). The cumulative success according to criterion A and B was 66.7% in the glaucoma surgeon group and 47.1% in the others surgeon group (P = 0.661). Repeated glaucoma surgery was required in 33.3% and 52.9% of the patients in the glaucoma surgeon and cornea trained surgeons groups, respectively (P = 0.661). Although there was a significant difference for IOP among various follow-up periods (p = 0.004), this difference was not significant between the two groups (p = 0.374).Visual Acuity did not have a signifiant difference between various follow-up periods and surgeons groups (p = 0.419 and P = 0. 690, respectively).
CONCLUSION: There were comparable outcomes with regard to complications and success rates between glaucoma surgeons and cornea trained surgeons performing AGV surgery.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Ahmed glaucoma valve; Glaucoma; Intraocular pressure

Mesh:

Year:  2021        PMID: 34725769     DOI: 10.1007/s10792-021-02103-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  36 in total

1.  Improving glaucoma filtering surgery.

Authors:  M Papadopoulos; P T Khaw
Journal:  Eye (Lond)       Date:  2001-04       Impact factor: 3.775

2.  Safe trabeculectomy technique: long term outcome.

Authors:  I Stalmans; A Gillis; A-S Lafaut; T Zeyen
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  New implant for drainage in glaucoma. Clinical trial.

Authors:  A C Molteno
Journal:  Br J Ophthalmol       Date:  1969-09       Impact factor: 4.638

Review 4.  A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical Operations.

Authors:  Ivano Riva; Gloria Roberti; Andreas Katsanos; Francesco Oddone; Luciano Quaranta
Journal:  Adv Ther       Date:  2017-03-11       Impact factor: 3.845

5.  Tight junction formation in the establishment of intramembranous particle polarity in aggregating MDCK cells. Effect of drug treatment.

Authors:  U H Sang; M H Saier; M H Ellisman
Journal:  Exp Cell Res       Date:  1980-07       Impact factor: 3.905

6.  The National Survey of Trabeculectomy. II. Variations in operative technique and outcome.

Authors:  B Edmunds; J R Thompson; J F Salmon; R P Wormald
Journal:  Eye (Lond)       Date:  2001-08       Impact factor: 3.775

7.  Three-year follow-up of the tube versus trabeculectomy study.

Authors:  Steven J Gedde; Joyce C Schiffman; William J Feuer; Leon W Herndon; James D Brandt; Donald L Budenz
Journal:  Am J Ophthalmol       Date:  2009-08-11       Impact factor: 5.258

Review 8.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

Authors:  Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

Review 9.  Influence of Trace Elements on Neurodegenerative Diseases of The Eye-The Glaucoma Model.

Authors:  Agnieszka Kamińska; Giovanni Luca Romano; Robert Rejdak; Sandrine Zweifel; Michal Fiedorowicz; Magdalena Rejdak; Anahita Bajka; Rosario Amato; Claudio Bucolo; Teresio Avitabile; Filippo Drago; Mario Damiano Toro
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

10.  Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant.

Authors:  Tai Jun Kim; Sohyun Kang; Jin Wook Jeoung; Young Kook Kim; Ki Ho Park
Journal:  BMC Ophthalmol       Date:  2018-02-14       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.